| 11. | Arginase deficiency typically refers to decreased function of arginase I, the liver isoform of arginase.
|
| 12. | Arginase deficiency typically refers to decreased function of arginase I, the liver isoform of arginase.
|
| 13. | Arginase deficiency typically refers to decreased function of arginase I, the liver isoform of arginase.
|
| 14. | Arginase is a binuclear manganese metallopritein that catalyse the hydrolysis of L-arginine to L-ornithine and urea.
|
| 15. | The ureohydrolase superfamily includes arginase ( ), agmatinase ( ), formiminoglutamase ( ) and proclavaminate amidinohydrolase ( ).
|
| 16. | The second isozyme, Arginase II, has been implicated in the regulation of the arginine / ornithine concentrations in the cell.
|
| 17. | N-hydroxy-L-arginine ( NOHA ), an intermediate of NO biosynthesis, is a moderate inhibitor of arginase.
|
| 18. | Release of arginase, proline, polyaminases and TGF-? by the activated M2 cell is tied with wound repair and fibrosis.
|
| 19. | Arginase is used to decrease the arginine levels in blood serum in order to starving the cancer cells that are auxotrophic to arginine aminoacid.
|
| 20. | The evidence of boronic acid mimic as transitions state analogue inhibitor was elucidated by x-ray crystal structure complex with human arginase I.
|
